Wacker has acquired the manufacturing assets and know-how of U.S.-based Bio Med Sciences Inc. to expand its expertise and business in silicone-coated healthcare products.
As part of the acquisition, a majority of Bio Med Sciences' workforce will move to Wacker. Both parties have agreed not to disclose the purchase price.
The acquired assets and a majority of the workforce will be part of a new legal entity called Wacker Silicone Manufactured Innovations LLC (WSMI). The entity, a wholly owned subsidiary of Wacker Chemical Corporation, will serve customers and offer prototype development, technical and contract manufacturing services to the medical device and wound care markets. The business is based in Allentown, Pennsylvania, USA. Existing consumer products and related brands will remain with BioMed Sciences and are not part of the acquisition.
Related: Beauty Manufacturing Trends: 6 Dimensions of Sustainability
Christian Kirsten, Wacker board member, commented: "By taking over Bio Med Sciences' assets, technology and know-how, we are now a solution provider for the health care industry. We can support and collaborate with customers who are looking for innovative adhesive coating solutions in the healthcare sector even better. This new business perfectly complements our existing solutions of silicone-based gel adhesives for medical and cosmetic applications."
